Search Filters

Search Results

Found 2 results

510(k) Data Aggregation

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    Triathlon® Hinge Knee System is intended to be implanted with bone cement for the following condition(s):

    • There is destruction of the joint surfaces, with or without significant bone deformity.
    • The cruciate and/or collateral ligaments do not stabilize the knee joint.
    • The ligaments are inadequate and/or the musculature is weak. And/or
    • Revision is required of a failed prosthesis where there has been gross instability, with or without bone loss or inadequate soft tissue.

    When used with MRH femur and/or MRH tibial baseplate replacement indicated in revision of an existing prosthesis:

    • Revision is required of a failed prosthesis where there has been gross instability, with or without bone loss or inadequate soft tissue.

    When used with compatible GMRS components:

    • Where segmental resection and/or replacement of femur and/or proximal tibia is required
    Device Description

    The subject THK components are a line extension of the previously cleared Triathlon® Hinge Knee System (K223528, K230416). The THK System (K223528, K230416) is a tricompartmental knee system consisting of a stemmed femoral component and a stemmed tibial bearing component connected by a set of previously cleared MRH or THK Bushings and an MRH or THK Axle (K994207, K002552, K223528, K230416). A bumper locks this assembly. This assembly provides motion through the MRH or THK Axle/Bushings combination in the flexion/extension plane. The articulation between the bearing surfaces on the underside of a tibial bearing component and a tibial insert provides motion in the rotating plane. A hinge tibial insert is assembled to a Triathlon® Hinge Revision Tibial Baseplate that incorporates a longitudinal bore to accept a previously cleared MRH Tibial Sleeve (K994207, K002552) or Triathlon Tibial Sleeve (K223528, K230416). Optional distal femoral and tibial augments are available to fill bone defects.

    The subject Triathlon® Hinge Small Proximal Tibial Bearing Component and Triathlon® End Cap are sterile, single use devices intended for cemented use only and are being added to the previously cleared THK system (K223528, K230416) as an extension. They can be used with previously cleared MRH Knee components (K994207, K002552), GMRS (K023087, K222056), and Triathlon® Knee System components (K172634, K172326, K190991, K143393, K141056, K132624, K070095, K061521, K053514, K052917, K051948, K051146, K040267).

    AI/ML Overview

    This FDA 510(k) clearance letter is for a mechanical medical device (a knee implant system), not an AI/software as a medical device. Therefore, the request for "acceptance criteria and the study that proves the device meets the acceptance criteria" using metrics relevant to AI/software (like sensitivity, specificity, MRMC studies, ground truth for training/test sets, etc.) is not applicable here.

    The document provided details about the substantial equivalence of the "Triathlon® Hinge Knee System" to previously cleared predicate devices. The "study" proving the device meets acceptance criteria for a mechanical implant typically involves non-clinical (benchtop) testing and engineering analyses to demonstrate performance, material compatibility, and safety, rather than clinical trials or AI performance evaluations with ground truth.

    Here's how the provided information relates to the typical evaluation of such a device, addressing the closest analogues to your requested points:


    Acceptance Criteria and Device Performance for a Mechanical Implant:

    For mechanical implants like the Triathlon® Hinge Knee System, "acceptance criteria" are generally tied to the successful completion of various non-clinical (benchtop) tests and analyses. These tests simulate the physical stresses and conditions the implant will experience in the human body. The "study" proving the device meets these criteria is the execution and successful outcome of these non-clinical tests.

    No direct table of "acceptance criteria" vs. "reported device performance" in the AI sense is provided in this 510(k) summary. Instead, the summary lists the types of non-clinical tests performed to demonstrate performance and substantial equivalence to predicate devices. The implied acceptance is that the device passed these tests, meaning its performance in these simulated scenarios was deemed acceptable and comparable to existing, legally marketed devices.

    Table of Non-Clinical Tests (Analogous to Performance Metrics):

    Acceptance Criteria (Test Type)Reported Device Performance (Implied "Pass")Notes
    Triathlon Hinge Bearing Component Varus/Valgus FatigueMet performance standardsTests the component's ability to withstand repeated bending stresses in side-to-side directions, simulating loading during gait.
    Triathlon Hinge Bearing Component Chair Rise TestingMet performance standardsSimulates stresses experienced during a common activity (standing up from a chair).
    Triathlon Hinge Full Construct FatigueMet performance standardsEvaluates the fatigue life of the entire assembled knee system under cyclic loading.
    Wear Test Rationale for New ConstructsAcceptable wear characteristics demonstratedRationale provided to show that wear performance is acceptable, likely through comparison to predicate devices or established standards. Direct wear testing is implied by "wear test rationale".
    Analysis of Contact Area/Contact Stress & Constraint AnalysisAcceptable contact mechanics & constraintComputer modeling and/or benchtop tests to evaluate how the components interact under load, ensuring appropriate stress distribution and constrained movement.
    Range of Motion and Rotational Freedom Analysis (ASTM F1223-20)Met specified ranges and freedomsTested for flexion/extension, internal/external rotation, varus/valgus, and translation (medial/lateral, proximal/distal, anterior/posterior) to ensure physiological movement.
    Total Femur Construct Compatibility & Triathlon Hinge Bushing/Axle CompatibilityCompatible with legacy componentsEnsured new components integrate properly with existing cleared femoral and tibial components.
    Triathlon Revision Baseplate-End Cap Locking Strength AnalysisAdequate locking strengthEvaluated the mechanical strength of the connection points.
    Triathlon End Cap Tightening AnalysisOptimal tightening confirmedEnsured secure fixation of the end cap.
    Triathlon End Cap Load Carrying Capacity RationaleAcceptable load capacityAnalysis provided to demonstrate the end cap can withstand expected loads.
    Triathlon End Cap Stability AnalysisStable under normal useEvaluated the end cap's ability to remain in place and function without loosening.
    MRI Testing (Safety for imaging) - Displacement, Torque, Artifacts, RF HeatingAll MRI safety criteria metPerformed to confirm the device is safe for patients undergoing MRI procedures (e.g., no excessive magnetic pull, acceptable image distortion, no dangerous heating). Standards: ASTM F2052-15, ASTM F2213-17, ASTM F2119-07 (reapproved 2013), ASTM F2182-191ae.
    Biocompatibility (ISO 10993-1:2020)Biocompatible with human tissueTesting to ensure the materials used in the implant do not cause adverse biological reactions in the body.
    Shelf-life Validation (ISO 11607-1:2019, ISO 11607-2:2019, ASTM F1980-21)Validated shelf-lifeEnsures the sterility and integrity of the packaging system and the device itself are maintained over the specified shelf-life. Methods: ASTM F1886/F1886M-16, ASTM F88/88M-21, ASTM F2096-11(2019).
    Bacterial Endotoxin Testing (ANSI/AAMI ST72:2019)Endotoxin limit
    Ask a Question

    Ask a specific question about this device

    Why did this record match?
    Reference Devices :

    K190991

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The ReUnion RFX System includes a Reversible Fracture Stem (RFX Stem) that can utilize either the ReUnion Total Shoulder Arthroplasty (TSA) or ReUnion Reverse Shoulder Arthroplasty (RSA) humeral and glenoid components and is indicated for use as a hemi, total or reverse shoulder replacement. The ReUnion RFX stem is intended for cemented use only.

    When used with ReUnion TSA Humeral & Glenoid Components
    The ReUnion RFX System, when used with ReUnion TSA Humeral and Glenoid components, is indicated for use as a Hemi or Total Shoulder Replacement:

    • Aseptic necrosis of the humeral head.
    • Painful, disabling joint disease of the shoulder resulting from: degenerative arthritis, rheumatoid arthritis, or post-traumatic arthritis.
    • Proximal humeral fractures and/or dislocation.
    • Clinical management problems where arthrodesis or alternative reconstructive techniques are less likely to achieve satisfactory results.
    • Revision of previous unsuccessful total shoulder replacement, resurfacing or other procedure.
      In the case of revision, when ReUnion RFX humeral stems are well fixed, the system is indicated for conversion to a total shoulder arthroplasty. In conjunction with ReUnion TSA humeral and glenoid components, if the natural glenoid provides sufficient bone stock, ReUnion RFX humeral stems can be converted from a hemiarthroplasty to a total shoulder arthroplasty, as well as revised from an existing total shoulder arthroplasty to a secondary total shoulder arthroplasty. It is also indicated for conversion to a hemiarthroplasty. In conjunction with ReUnion TSA humeral components, ReUnion RFX humeral stems can be converted from a total or reverse shoulder arthroplasty to a hemiarthroplasty, as well as revised from an existing hemiarthroplasty to a secondary hemiarthroplasty, in treatment of previously failed shoulder arthroplasty cases where revision to a reverse shoulder arthroplasty is inappropriate.
      The glenoid components are intended for cemented use only.

    When used with ReUnion RSA Humeral & Glenoid Components
    The ReUnion RFX System, when used with ReUnion RSA humeral & glenoid components, is intended for primary, fracture, or revision total shoulder replacement. The patient's joint must have gross rotator cuff deficiency, a functional deltoid muscle, and be anatomically and structurally suited to receive the implant(s).

    • Painful, disabling joint disease of the shoulder resulting from degenerative arthritis or rheumatoid arthritis;
    • Proximal humeral fractures
    • Revisions of previously failed shoulder joint replacements
      In the case of revision, when ReUnion RFX humeral stems are well fixed, the system is indicated for conversion to a reverse shoulder arthroplasty. In conjunction with ReUnion RSA humeral and glenoid components, ReUnion RFX humeral stems can be converted from a hemi or total shoulder arthroplasty to a reverse shoulder arthroplasty, as well as revised from an existing reverse shoulder arthroplasty to a secondary reverse shoulder arthroplasty, in treatment of a grossly deficient rotator cuff with severe arthropathy or previously failed joint replacement with a grossly deficient rotator cuff. The patient must have a functional deltoid muscle, and be anatomically and structurally suited to receive the implant(s).
      Glenoid Baseplate components are intended for cementless use with the addition of screw fixation.

    The ReUnion RSA Shoulder System is intended for primary, fracture, or revision of total Shoulder replacement. The patient's joint must be anatomically suited to receive the selected implant(s), and a functional deltoid muscle is necessary to use the device.
    The patient's joint must have gross rotator cuff deficiency, a functional deltoid muscle and be anatomically and structurally suited to receive the selected implant(s).

    • Painful, disabling joint disease of the shoulder resulting from: degenerative arthritis or rheumatoid arthritis.
    • Proximal humeral fracture.
    • Revision of previously failed shoulder joint replacement.
      Glenoid Baseplate components are intended for cementless use with the addition of screw fixation.
      The Humeral Stem components are intended for both cemented and cementless use.
      In the case of revision, when ReUnion TSA humeral stems are well fixed, the system is indicated for conversion to a reverse shoulder arthroplasty.
      In conjunction with ReUnion RSA humeral and glenoid components, ReUnion TSA humeral stems can be converted from a hemi or total shoulder arthroplasty to a reverse shoulder arthroplasty, as well as revised from an existing reverse shoulder arthroplasty to a secondary reverse shoulder arthroplasty, in treatment of a grossly deficient rotator cuff with severe arthroplasty failed joint replacement with a grossly deficient rotator cuff. The patient must have a functional deltoid muscle, and be anatomically and structurally suited to receive the implant(s).

    For use as a Hemi or Total Shoulder Replacement

    • Aseptic necrosis of the humeral head.
    • Painful, disabling joint disease of the shoulder resulting from: degenerative arthritis, rheumatoid arthritis or posttraumatic arthritis.
    • Proximal humeral fracture and/or dislocation.
    • Clinical management problems where arthrodesis or alternative reconstructive techniques are less likely to achieve satisfactory results.
    • Revision of previous unsuccessful total shoulder replacement, resurfacing or other procedure.
      Glenoid components are intended for cemented use only. The humeral stem components are intended for both cemented and cementless use.
      In the case of revision, when ReUnion TSA humeral stems are well fixed, the system is indicated for conversion to a total shoulder arthroplasty. In conjunction with ReUnion TSA humeral and glenoid components, if the natural glenoid provides sufficient bone stock, ReUnion TSA humeral stems can be converted from a hemiarthroplasty to a total shoulder arthroplasty, as well as revised from an existing total shoulder arthroplasty to a secondary total shoulder arthroplasty. It is also indicated for conversion to a hemiarthroplasty. In conjunction with ReUnion TSA humeral components, ReUnion TSA humeral stems can be converted from a total or ReUnion RSA reverse shoulder arthroplasty to a hemiarthroplasty, as well as revised from an existing hemiarthroplasty to a secondary hemiarthroplasty, in treatment of previously failed shoulder arthroplasty cases where revision to a reverse shoulder arthroplasty is inappropriate.
    Device Description

    This Traditional 510(k) submission is being supplied to the U.S. FDA to provide authorization to market a modified device within the ReUnion RSA System. The modification is to:

    • introduce the additively manufactured ReUnion RSA Baseplate glenoid component to the existing ReUnion Shoulder Platform. The additively manufactured RSA Baseplate consists of a unique configuration of both solid and porous structures that are simultaneously built using Laser Rapid Manufacturing (LRM) method applying Stryker's proprietary Tritanium® In-Growth Technology. The porous Tritanium® coating is designed to achieve biological fixation.
    • The modification to the Subject Device also includes several minor design and dimensional modifications.
      The Subject Device RSA Baseplate has the same Intended Use and Indications for Use as the Predicate Device, and shares the same operative technique.

    ReUnion Reversible Fracture System (RFX)
    The ReUnion Reversible Fracture System consists of a humeral fracture stem component which may be used in conjunction with TSA or RSA humeral and glenoid components for conventional total shoulder arthroplasty or reverse shoulder arthroplasty. It may also be used in conjunction with TSA humeral components to articulate directly with the anatomic glenoid in a hemi-shoulder application. The device contains various number of suture holes. The stems have a female taper on the proximal end of the shaft to accept TSA and RSA Gleno-humeral components. It is designed to be used in cemented applications only.

    ReUnion Reverse Shoulder Arthroplasty System (RSA)
    The ReUnion RSA Shoulder System is a system of components intended for total shoulder replacement in a reverse shoulder configuration. The system is comprised of a humeral insert, glenosphere, glenoid baseplate and screws. The Humeral Cup with the Humeral Insert are attached to the humeral side of the joint via the ReUnion TSA Humeral Stem while the Glenosphere is implanted with the Glenoid Baseplate onto the glenoid side of the joint fixated with locking Center and Peripheral Screws.

    ReUnion Total Shoulder Arthroplasty System (TSA)
    The Reunion Total Shoulder Arthroplasty (TSA) System is intended for shoulder arthroplasty. The components of this system consist of humeral stems, a modular humeral neck adapter, single radius humeral heads, and self-pressurizing glenoids (SPG). The humeral stem is offered in both cemented and cementless designs. The cementless humeral stem design features a circumferential Ti-plasma spray and hydroxyapatite (HA) coating at the proximal end and the cemented humeral stems have no coating at the proximal end. These humeral stems were designed to mate with the subject single radius humeral heads or the modular neck adapter, for compatibility with other marketed humeral heads. The self-pressuring glenoids (SPG) mate with the single radius heads. The SPGs are offered in both pegged and keeled configurations.

    AI/ML Overview

    The provided text is a 510(k) Summary for medical devices, specifically orthopedic implants (shoulder arthroplasty systems). This type of document is used to demonstrate substantial equivalence to a predicate device, not necessarily to provide detailed performance studies of a novel AI/software medical device.

    Therefore, the input document does not contain the information requested in points 1-9 regarding acceptance criteria and performance studies for an AI/software device. The document primarily focuses on explaining the device's indications for use, its components, and how it is substantially equivalent to existing predicate devices, particularly highlighting a modification to the RSA Baseplate involving an additive manufacturing process and emphasizing non-clinical tests for mechanical properties and biocompatibility.

    Here's why the requested information is not present:

    • Acceptance Criteria and Reported Device Performance (1): The document discusses non-clinical testing for fatigue, taper strength, and micromotion, stating "all acceptance criteria was fulfilled." However, it does not provide specific numerical acceptance criteria or detailed performance results in the format of a table as requested.
    • Sample Size, Ground Truth, Adjudication (2, 3, 4, 7, 8, 9): These points relate to studies involving data sets, expert review, and ground truth establishment, which are typical for studies validating AI/software performance. This document clearly states, "Clinical testing was not required for this submission." This indicates that no studies involving human interpretation of data (which would require ground truth, experts, and adjudication) were performed for this 510(k) submission. The validation here is primarily on the physical and material characteristics of the orthopedic implant.
    • MRMC Comparative Effectiveness Study (5): Since no clinical testing or human-in-the-loop studies were conducted, an MRMC comparative effectiveness study with or without AI assistance is not applicable and not discussed.
    • Standalone Performance (6): Similarly, since this is a mechanical implant and not an AI algorithm, the concept of "standalone performance" for an algorithm is not applicable.

    In summary, the provided FDA 510(k) document is for a physical orthopedic implant system, and its content focuses on demonstrating substantial equivalence through design comparisons, material characterization, and mechanical testing, rather than performance metrics related to an AI/software component as implied by the questions.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1